Index
1 Market Overview of NSAIDs Drug
1.1 NSAIDs Drug Market Overview
1.1.1 NSAIDs Drug Product Scope
1.1.2 NSAIDs Drug Market Status and Outlook
1.2 Global NSAIDs Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global NSAIDs Drug Market Size by Region (2018-2029)
1.4 Global NSAIDs Drug Historic Market Size by Region (2018-2023)
1.5 Global NSAIDs Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, NSAIDs Drug Market Size (2018-2029)
1.6.1 North America NSAIDs Drug Market Size (2018-2029)
1.6.2 Europe NSAIDs Drug Market Size (2018-2029)
1.6.3 Asia-Pacific NSAIDs Drug Market Size (2018-2029)
1.6.4 Latin America NSAIDs Drug Market Size (2018-2029)
1.6.5 Middle East & Africa NSAIDs Drug Market Size (2018-2029)
2 NSAIDs Drug Market by Type
2.1 Introduction
2.1.1 Ibuprofen
2.1.2 Naproxen
2.2 Global NSAIDs Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global NSAIDs Drug Historic Market Size by Type (2018-2023)
2.2.2 Global NSAIDs Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Type (2018-2029)
3 NSAIDs Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Drugstores
3.2 Global NSAIDs Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global NSAIDs Drug Historic Market Size by Application (2018-2023)
3.2.2 Global NSAIDs Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Application (2018-2029)
4 NSAIDs Drug Competition Analysis by Players
4.1 Global NSAIDs Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)
4.3 Date of Key Players Enter into NSAIDs Drug Market
4.4 Global Top Players NSAIDs Drug Headquarters and Area Served
4.5 Key Players NSAIDs Drug Product Solution and Service
4.6 Competitive Status
4.6.1 NSAIDs Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer NSAIDs Drug Products, Services and Solutions
5.1.4 Pfizer NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK NSAIDs Drug Products, Services and Solutions
5.2.4 GSK NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.2.5 GSK Recent Developments
5.3 Grunenthal
5.3.1 Grunenthal Profile
5.3.2 Grunenthal Main Business
5.3.3 Grunenthal NSAIDs Drug Products, Services and Solutions
5.3.4 Grunenthal NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer NSAIDs Drug Products, Services and Solutions
5.4.4 Bayer NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi NSAIDs Drug Products, Services and Solutions
5.5.4 Sanofi NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly NSAIDs Drug Products, Services and Solutions
5.6.4 Eli Lilly NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca NSAIDs Drug Products, Services and Solutions
5.7.4 AstraZeneca NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Endo
5.8.1 Endo Profile
5.8.2 Endo Main Business
5.8.3 Endo NSAIDs Drug Products, Services and Solutions
5.8.4 Endo NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Endo Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck NSAIDs Drug Products, Services and Solutions
5.9.4 Merck NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Depomed
5.10.1 Depomed Profile
5.10.2 Depomed Main Business
5.10.3 Depomed NSAIDs Drug Products, Services and Solutions
5.10.4 Depomed NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Depomed Recent Developments
5.11 Yunnan Baiyao
5.11.1 Yunnan Baiyao Profile
5.11.2 Yunnan Baiyao Main Business
5.11.3 Yunnan Baiyao NSAIDs Drug Products, Services and Solutions
5.11.4 Yunnan Baiyao NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Yunnan Baiyao Recent Developments
5.12 Teva
5.12.1 Teva Profile
5.12.2 Teva Main Business
5.12.3 Teva NSAIDs Drug Products, Services and Solutions
5.12.4 Teva NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.12.5 Teva Recent Developments
5.13 J&J
5.13.1 J&J Profile
5.13.2 J&J Main Business
5.13.3 J&J NSAIDs Drug Products, Services and Solutions
5.13.4 J&J NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.13.5 J&J Recent Developments
5.14 Allergan
5.14.1 Allergan Profile
5.14.2 Allergan Main Business
5.14.3 Allergan NSAIDs Drug Products, Services and Solutions
5.14.4 Allergan NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.14.5 Allergan Recent Developments
5.15 Purdue
5.15.1 Purdue Profile
5.15.2 Purdue Main Business
5.15.3 Purdue NSAIDs Drug Products, Services and Solutions
5.15.4 Purdue NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.15.5 Purdue Recent Developments
6 North America
6.1 North America NSAIDs Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NSAIDs Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NSAIDs Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NSAIDs Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NSAIDs Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NSAIDs Drug Market Dynamics
11.1 NSAIDs Drug Industry Trends
11.2 NSAIDs Drug Market Drivers
11.3 NSAIDs Drug Market Challenges
11.4 NSAIDs Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List